HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B.

AuthorsYoshitaka Ueno, Shinji Tanaka, Masaru Shimamoto, Yoshihiro Miyanaka, Toru Hiyama, Masanori Ito, Yasuhiko Kitadai, Masaharu Yoshihara, Masaharu Sumii, Kazuaki Chayama
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 50 Issue 1 Pg. 163-6 (Jan 2005) ISSN: 0163-2116 [Print] United States
PMID15712655 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • DNA, Viral
  • Gastrointestinal Agents
  • Infliximab
  • Aspartate Aminotransferases
  • Alanine Transaminase
Topics
  • Adolescent
  • Alanine Transaminase (blood)
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Aspartate Aminotransferases (blood)
  • Colonoscopy
  • Crohn Disease (complications, drug therapy, pathology)
  • DNA, Viral (blood)
  • Female
  • Gastrointestinal Agents (adverse effects, therapeutic use)
  • Hepatitis B virus (drug effects, genetics)
  • Hepatitis B, Chronic (complications, virology)
  • Humans
  • Infliximab
  • Rectovaginal Fistula (complications, diagnostic imaging)
  • Time Factors
  • Ultrasonography
  • Virus Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: